Brian K. Adler

2.4k total citations
24 papers, 928 citations indexed

About

Brian K. Adler is a scholar working on Molecular Biology, Epidemiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Brian K. Adler has authored 24 papers receiving a total of 928 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Epidemiology and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Brian K. Adler's work include Trypanosoma species research and implications (7 papers), RNA regulation and disease (4 papers) and Atrial Fibrillation Management and Outcomes (3 papers). Brian K. Adler is often cited by papers focused on Trypanosoma species research and implications (7 papers), RNA regulation and disease (4 papers) and Atrial Fibrillation Management and Outcomes (3 papers). Brian K. Adler collaborates with scholars based in United States, Australia and Germany. Brian K. Adler's co-authors include Stephen L. Hajduk, Michael E. Harris, Ines Batinić‐Haberle, Thomas M. Ryan, Albert Tousson, Dale A. Parks, Bruce Α. Freeman, Mark T. Gladwin, C. Roger White and Rakesh P. Patel and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Blood.

In The Last Decade

Brian K. Adler

23 papers receiving 880 citations

Peers

Brian K. Adler
Michael A. Fournel United States
Franco Quagliata United States
C Bunch United Kingdom
Robert I. Roth United States
Brian K. Adler
Citations per year, relative to Brian K. Adler Brian K. Adler (= 1×) peers Michiari Okuda

Countries citing papers authored by Brian K. Adler

Since Specialization
Citations

This map shows the geographic impact of Brian K. Adler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian K. Adler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian K. Adler more than expected).

Fields of papers citing papers by Brian K. Adler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian K. Adler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian K. Adler. The network helps show where Brian K. Adler may publish in the future.

Co-authorship network of co-authors of Brian K. Adler

This figure shows the co-authorship network connecting the top 25 collaborators of Brian K. Adler. A scholar is included among the top collaborators of Brian K. Adler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian K. Adler. Brian K. Adler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Limdi, Nita A., Donna K. Arnett, Joyce A. Goldstein, et al.. (2008). Influence of CYP2C9 and VKORC1 on Warfarin Dose, Anticoagulation Attainment and Maintenance Among European–Americans and African–Americans. Pharmacogenomics. 9(5). 511–526. 111 indexed citations
2.
3.
Dillmon, Melissa S., Michael S. Saag, Sate Hamza, Brian K. Adler, & Marisa B. Marques. (2005). Unusual Thromboses Associated with Protein S Deficiency in Patients with Acquired Immunodeficiency Syndrome: Case Reports and Review of the Literature. AIDS Research and Human Retroviruses. 21(9). 753–756. 20 indexed citations
4.
Hügle, Boris, Heide Hellebrand, Brian K. Adler, et al.. (2004). Persistent Hypogammaglobulinemia Following Mononucleosis in Boys Is Highly Suggestive of X-Linked Lymphoproliferative Disease—Report of Three Cases. Journal of Clinical Immunology. 24(5). 515–522. 9 indexed citations
5.
Adler, Brian K., et al.. (2003). The Effect of Lupus Anticoagulant in the Second-Generation Assay for Activated Protein C Resistance. American Journal of Clinical Pathology. 119(1). 66–71. 8 indexed citations
6.
Ragland, Brian D., et al.. (2003). The Effect of Lupus Anticoagulant in the Second-Generation Assay for Activated Protein C Resistance. American Journal of Clinical Pathology. 119(1). 66–71. 9 indexed citations
7.
Marques, Marisa B., et al.. (2003). Clinical Pathology Consultation Improves Coagulation Factor Utilization in Hospitalized Adults. American Journal of Clinical Pathology. 120(6). 938–943. 4 indexed citations
8.
Aslan, Mutay, Thomas M. Ryan, Brian K. Adler, et al.. (2001). Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease. Proceedings of the National Academy of Sciences. 98(26). 15215–15220. 312 indexed citations
9.
McManus, Michael T., Brian K. Adler, Victoria W. Pollard, & Stephen L. Hajduk. (2000). Trypanosoma brucei Guide RNA Poly(U) Tail Formation Is Stabilized by Cognate mRNA. Molecular and Cellular Biology. 20(3). 883–891. 33 indexed citations
10.
Sabatini, Robert, Brian K. Adler, Susan Madison‐Antenucci, Michael T. McManus, & Stephen L. Hajduk. (1998). Biochemical Methods for Analysis of Kinetoplastid RNA Editing. Methods. 15(1). 15–26. 14 indexed citations
11.
Adler, Brian K. & Stephen L. Hajduk. (1997). Guide RNA Requirement for Editing-Site-Specific Endonucleolytic Cleavage of Preedited mRNA by Mitochondrial Ribonucleoprotein Particles in Trypanosoma brucei. Molecular and Cellular Biology. 17(9). 5377–5385. 17 indexed citations
12.
Prchal, Josef T., Brian K. Adler, J. B. Wilson, et al.. (1995). HB Bibba OR α2136(H19)LEU→PROβ2in a Caucasian Family from Alabama. Hemoglobin. 19(3-4). 151–164. 2 indexed citations
13.
Adler, Brian K. & Stephen L. Hajduk. (1994). Mechanisms and origins of RNA editing. Current Opinion in Genetics & Development. 4(2). 316–322. 18 indexed citations
14.
Michelotti, Emil F., Michael E. Harris, Brian K. Adler, Al F. Torri, & Stephen L. Hajduk. (1992). Trypanosoma brucei mitochondrial ribosomal RNA synthesis, processing and developmentally regulated expression. Molecular and Biochemical Parasitology. 54(1). 31–41. 37 indexed citations
15.
Hajduk, Stephen L., Brian K. Adler, Kathy Hancock, et al.. (1992). Molecular Biology of African Trypanosomes: Development of New Strategies to Combat an Old Disease. The American Journal of the Medical Sciences. 303(4). 258–270. 29 indexed citations
16.
Adler, Brian K., et al.. (1991). Modification of Trypanosoma brucei Mitochondrial rRNA by Posttranscriptional 3' Polyuridine Tail Formation. Molecular and Cellular Biology. 11(12). 5878–5884. 64 indexed citations
17.
Adler, Brian K., et al.. (1991). Modification of Trypanosoma brucei mitochondrial rRNA by posttranscriptional 3' polyuridine tail formation.. Molecular and Cellular Biology. 11(12). 5878–5884. 46 indexed citations
18.
Zinkernagel, Rolf M., Brian K. Adler, & John J. Holland. (1978). Cell-Mediated Immunity to Vesicular Stomatitis Virus Infections in Mice. Pathobiology. 46(1-2). 53–70. 49 indexed citations
19.
Zinkernagel, R M, Alana Althage, Brian K. Adler, et al.. (1977). H-2 restriction of cell-mediated immunity to an intracellular bacterium: effector T cells are specific for Listeria antigen in association with H-21 region-coded self-markers.. The Journal of Experimental Medicine. 145(5). 1353–1367. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026